The latest closing stock price for Barinthus Biotherapeutics as of November 22, 2024 is 0.89.
An investor who bought $1,000 worth of Barinthus Biotherapeutics stock at the IPO in 2021 would have $-937 today, roughly -1 times their original investment - a -49.81% compound annual growth rate over 4 years.
The all-time high Barinthus Biotherapeutics stock closing price was 17.00 on May 17, 2021.
The Barinthus Biotherapeutics 52-week high stock price is 4.16, which is 367.4% above the current share price.
The Barinthus Biotherapeutics 52-week low stock price is 0.81, which is 9% below the current share price.
The average Barinthus Biotherapeutics stock price for the last 52 weeks is 2.10.
An investor who bought $1,000 worth of Barinthus Biotherapeutics stock at the IPO in 2021 would have $-937 today, roughly -1 times their original investment - a -49.81% compound annual growth rate over 4 years.
The all-time high Barinthus Biotherapeutics stock closing price was 17.00 on May 17, 2021.
The Barinthus Biotherapeutics 52-week high stock price is 4.16, which is 367.4% above the current share price.
The Barinthus Biotherapeutics 52-week low stock price is 0.81, which is 9% below the current share price.
The average Barinthus Biotherapeutics stock price for the last 52 weeks is 2.10.